Molecular design based on 3D-pharmacophore. Application to 5-HT subtypes receptors.
A first definition of a pharmacophore for the serotonin reuptake inhibitors was carried out by considering a three-dimensional model which correlates the chemical structures of series of reuptake inhibitors with their biological affinities. A molecular design was described by analyzing two different 3D serotonin pharmacophores. This successful approach enabled us to consider the design of new serotonin ligands by the same method.
Bureau
Ronan
R
Centre d'Etudes et de Recherche sur le Médicament de Normandie, Université de Caen, 1, rue Vaubénard, 14032 Caen, France.
Daveu
Cyril
C
Lancelot
Jean-Charles
JC
Rault
Sylvain
S
D015195:Drug Design; D011985:Receptors, Serotonin / Q000145:classification*; D017367:Selective Serotonin Reuptake Inhibitors / Q000737:chemistry*
D011985:Receptors, Serotonin; D017367:Selective Serotonin Reuptake Inhibitors